Avantor, Inc. (AVTR)
| Previous close | 29.69 |
| Open | 29.87 |
| Bid | 27.51 x 2200 |
| Ask | 31.30 x 1200 |
| Day's range | 29.86 - 30.61 |
| 52-week range | 6.66 - 30.73 |
| Volume | 2,933,371 |
| Avg. volume | 5,388,332 |
| Market cap | 17.622B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | 256.05 |
| EPS (TTM) | 0.12 |
| Earnings date | 03 Feb 2021 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 30.65 |
- Simply Wall St.
Do Institutions Own Avantor, Inc. (NYSE:AVTR) Shares?
The big shareholder groups in Avantor, Inc. ( NYSE:AVTR ) have power over the company. Institutions will often hold...
- PR Newswire
Avantor® to Report Fourth Quarter and Full Year 2020 Earnings and Host Earnings Call on Wednesday, February 3, 2021
Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies & applied materials industries, announced that it will release its financial results for the fourth quarter and full year 2020 after the market closes on Wednesday, February 3, 2021, and will hold a conference call on the same day to discuss the results at 5:00 p.m. Eastern Time.
- PR Newswire
Avantor® Announces Preliminary Fourth Quarter Unaudited Revenues and Estimated Free Cash Flow
Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies & applied materials industries, provided preliminary unaudited revenues and free cash flow estimates for the fourth quarter ended December 31, 2020 in conjunction with the Company's virtual presentation at the J.P. Morgan Healthcare Conference.
